• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:郑金琪,丁丽霞,洪利娅,张文勇,郑国钢.盐酸多柔比星脂质体注射液与葡萄糖和氯化钠注射液的配伍稳定性研究[J].中国现代应用药学,2013,30(11):1206-1210.
ZHENG Jinqi,DING Lixia ,HONG Liya ,ZHANG Wenyong,ZHENG Guogang.Disquisition on Stability of Mixture of Doxorubicin Hydrochloride Liposome Injection and Sodium Chloride Injection or Glucose Injection[J].Chin J Mod Appl Pharm(中国现代应用药学),2013,30(11):1206-1210.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3021次   下载 2566 本文二维码信息
码上扫一扫!
分享到: 微信 更多
盐酸多柔比星脂质体注射液与葡萄糖和氯化钠注射液的配伍稳定性研究
郑金琪1, 丁丽霞2, 洪利娅1, 张文勇3, 郑国钢1
1.浙江省食品药品检验研究院,杭州 310004;2.中国药学会,北京 100022;3.浙江海正药业股份有限公司,浙江 台州 318000
摘要:
目的 研究盐酸多柔比星脂质体注射液与5%葡萄糖注射液和0.9%氯化钠注射液的配伍稳定性。方法 盐酸多柔比星脂质体注射液分别与5%葡萄糖注射液和0.9%氯化钠注射液配伍后,考察配伍溶液的外观、pH值、脂质体的粒径、含量和包封率,采用HPLC测定含量,色谱柱为Lichrospher C18柱(250 mm×4.6 mm,5 μm),以含0.01 mol·L-1十二烷基硫酸钠的0.02 mol·L-1磷酸溶液-乙腈-甲醇(500∶500∶60)为流动相,流速1.0 mL·min-1,柱温30 ℃,检测波长254 nm,进样量20 μL;离子树脂交换法测定包封率。结果 盐酸多柔比星脂质体注射液与0.9%氯化钠注射液配伍后,6 h内溶液的外观、pH值、脂质体的粒径和含量均无变化,包封率下降约5%;与5%葡萄糖注射液配伍后,6 h内溶液外观、pH值、脂质体的粒径、含量和包封率均无变化。结论 临床中盐酸多柔比星脂质体注射液不宜与0.9%氯化钠注射液配伍,宜与5%葡萄糖注射液配伍。
关键词:  盐酸多柔比星脂质体注射液  葡萄糖注射液  氯化钠注射液  配伍稳定性  粒径  高效液相色谱法  含量  包封率
DOI:
分类号:
基金项目:科技部重大新药创制课题(2011ZX09303-001)
Disquisition on Stability of Mixture of Doxorubicin Hydrochloride Liposome Injection and Sodium Chloride Injection or Glucose Injection
ZHENG Jinqi1, DING Lixia 2, HONG Liya 1, ZHANG Wenyong3, ZHENG Guogang1
1.Zhejiang Institute for Food and Drug Control, Hangzhou 310004, China;2.Chinese Pharmaceutical Association, Beijing 100022, China;3.Zhejiang Haisun Pharmaceutical Co. Ltd., Taizhou 318000, China
Abstract:
OBJECTIVE To discuss the compatibility stability of Doxorubicin Hydrochloride Liposome Injection with Sodium Chloride Injection or Glucose Injection. METHODS After Doxorubicin Hydrochloride Liposome Injection mixed with Sodium Chloride Injection or Glucose Injection, the appearance, pH, particle diameter, content and encapsulation efficiency of the mixture was studied. A HPLC method with Lichrospher C18(250 mm×4.6 mm, 5 μm) was applied to determine the concentration of doxorubicin hydrochloride and the mobile phase was 0.02 mol·L-1 phosphoric acid solution (0.01 mol·L-1 sodium dodecyl sulfate)-acetonitrile-methanol(500∶500∶60) at the flow rate of 1.0 mL·min-1. The column temperature was 30 ℃ and the detective wavelength was 254 nm. Ion-exchange resin method was used to determine the encapsulation efficiency. RESULTS In 6 hours, there was no obvious change in the appearance, pH, particle diameter and content in the mixture of Sodium Chloride Injection. But the encapsulation efficiency decreased 5%. However, there was no obvious change in the mixture of Glucose Injection. CONCLUSION The mixture of Doxorubicin Hydrochloride Liposome Injection and Sodium Chloride Injection was unstability. Doxorubicin Hydrochloride Liposome Injection is compatible with Glucose Injection in clinic.
Key words:  Doxorubicin Hydrochloride Liposome Injection  Sodium Chloride Injection  Glucose Injection  compatibility stability  particle diameter  HPLC  content  encapsulation efficiency
扫一扫关注本刊微信